Your browser doesn't support javascript.
loading
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.
Karthikeyan, Swathi; Waters, Ian G; Dennison, Lauren; Chu, David; Donaldson, Joshua; Shin, Dong Ho; Rosen, D Marc; Gonzalez-Ericsson, Paula I; Sanchez, Violeta; Sanders, Melinda E; Pantone, Morgan V; Bergman, Riley E; Davidson, Brad A; Reed, Sarah C; Zabransky, Daniel J; Cravero, Karen; Kyker-Snowman, Kelly; Button, Berry; Wong, Hong Yuen; Hurley, Paula J; Croessmann, Sarah; Park, Ben Ho.
Afiliación
  • Karthikeyan S; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Waters IG; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dennison L; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Chu D; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Donaldson J; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Shin DH; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Rosen DM; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gonzalez-Ericsson PI; Department of Pathology, Microbiology, and Immunology, and.
  • Sanchez V; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Sanders ME; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Pantone MV; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Bergman RE; Department of Pathology, Microbiology, and Immunology, and.
  • Davidson BA; Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Reed SC; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Zabransky DJ; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Cravero K; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Kyker-Snowman K; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
  • Button B; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wong HY; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hurley PJ; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Croessmann S; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Park BH; Division of Hematology, Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center.
J Clin Invest ; 131(6)2021 03 15.
Article en En | MEDLINE | ID: mdl-33529175
ABSTRACT
Intratumor heterogeneity is an important mediator of poor outcomes in many cancers, including breast cancer. Genetic subclones frequently contribute to this heterogeneity; however, their growth dynamics and interactions remain poorly understood. PIK3CA and HER2 alterations are known to coexist in breast and other cancers. Herein, we present data that describe the ability of oncogenic PIK3CA mutant cells to induce the proliferation of quiescent HER2 mutant cells through a cell contact-mediated mechanism. Interestingly, the HER2 cells proliferated to become the major subclone over PIK3CA counterparts both in vitro and in vivo. Furthermore, this phenotype was observed in both hormone receptor-positive and -negative cell lines, and was dependent on the expression of fibronectin from mutant PIK3CA cells. Analysis of human tumors demonstrated similar HER2PIK3CA clonal dynamics and fibronectin expression. Our study provides insight into nonrandom subclonal architecture of heterogenous tumors, which may aid the understanding of tumor evolution and inform future strategies for personalized medicine.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: J Clin Invest Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: J Clin Invest Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...